Laparoscopic vs Open Liver Surgery for Colorectal Mets
Colorectal cancer frequently spreads to the liver during the disease course. Consequently, surgical resection offers the best chance for cure in these patients. Laparoscopic liver resection has emerged as a widely adopted minimally invasive alternative to open surgery. However, surgical teams needed definitive high-level evidence regarding long-term oncologic safety. Therefore, a new individual participant data meta-analysis pooled individual data from four randomized clinical trials.
Benefits of Laparoscopic Liver Resection
This comprehensive meta-analysis evaluated 761 total patients across all published randomized trials. Specifically, 384 patients underwent laparoscopic surgery, whereas 377 patients received open resection. Furthermore, the researchers utilized trial-adjusted regression models and robust g-computation. Overall, patients receiving laparoscopic surgery experienced a significant reduction in postoperative complications. In fact, the overall morbidity rate dropped from 27% in open surgery to 19% in the laparoscopic group.
Postoperative Morbidity and Safety Outcomes
Notably, the study revealed critical insights regarding patient subgroups. For instance, preoperative systemic chemotherapy altered the observed surgical benefits. In this subgroup, morbidity rates were 25% for laparoscopy and 24% for open surgery. Additionally, 90-day mortality remained low across both arms of the pooled analysis. The 90-day mortality rate was 1.8% after laparoscopic resection compared to 0.8% after open resection. Thus, laparoscopic approaches maintain an acceptable perioperative safety profile in carefully selected patients.
Long-Term Oncologic Equivalence
Long-term cancer control represents the primary benchmark for any oncologic surgery. Importantly, this analysis tracked patients for a median follow-up duration of 93 months. During this extended monitoring, overall survival did not differ between the two approaches. Similarly, disease-free survival rates were comparable between laparoscopic and open surgery cohorts. Hence, surgeons can confidently choose laparoscopic methods without compromising oncologic efficacy.
Frequently Asked Questions
Q1: What are the main advantages of laparoscopic liver resection for colorectal metastases?
Laparoscopic surgery significantly reduces postoperative complications compared to open surgery. Additionally, patients typically benefit from less postoperative pain and faster functional recovery.
Q2: Does laparoscopic liver surgery compromise long-term oncologic survival?
No, long-term survival outcomes remain comparable. After 93 months of median follow-up, both overall survival and disease-free survival showed no significant difference between laparoscopic and open resections.
Q3: How does preoperative chemotherapy affect surgical complication rates?
Preoperative chemotherapy appears to attenuate the complication advantages of laparoscopy. Specifically, complication rates were nearly identical between laparoscopic (25%) and open (24%) groups in pretreated patients.
References
- Olij B et al. Laparoscopic Versus Open Liver Resection for Colorectal Liver Metastases : An Individual Participant Data Meta-analysis of Four Randomized Clinical Trials. Ann Intern Med. 2026 Oct 27. doi: 10.7326/ANNALS-26-02171. PMID: 42932884.
- Fretland ÅA, Dagenborg VJ, Bjørnelv GMW, et al. Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial. Ann Surg. 2018;267(2):199-207.
- Syn NL, Kabir T, Koh YX, et al. Survival Advantage of Laparoscopic Versus Open Resection For Colorectal Liver Metastases: A Meta-analysis of Individual Patient Data From Randomized Trials and Propensity-score Matched Studies. Ann Surg. 2020;272(2):253-265.
